Sirtex expects approval for Chinese buyout

Liver cancer treatment manufacturer Sirtex Medical expects its $US1.4 billion ($1.87 billion) buyout by a Chinese consortium to will win regulatory approval in Australia and the United States despite diplomatic tensions with China.

The company agreed on Thursday to an offer from Beijing-based CDH Investments and its partner, China Grand Pharmaceutical and Healthcare Holdings, which trumped a bid from U.S.-based Varian Medical Systems.

Fri, 15/06/2018 - 15:46
ICBC Beijing

Chinese banks top world's largest companies list

Industrial and Commercial Bank of China and China Construction Bank have been named the world’s two largest public companies for the sixth consecutive year, as China’s banking sector hit around $US35 trillion in loans in 2018.

The Forbes Global 2000 list showed China and Hong Kong-headquartered firms accounted for 291 of the world’s 2,000 largest companies, with three other Chinese companies alongside ICBC and CCB in the top 10.

Thu, 07/06/2018 - 11:07